About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Type 1 Diabetes Development Halted in Lab

by Himabindu Venkatakrishnan on January 21, 2015 at 5:07 PM
Font : A-A+

 Type 1 Diabetes Development Halted in Lab

Preventing type 1 diabetes in animal model has been achieved by scientists. Type 1 diabetes is a chronic autoimmune disease that results from the destruction of insulin producing pancreatic beta cells.

Type I diabetes is a chronic autoimmune disease that occurs when the body's immune system destroys insulin producing pancreatic beta cells, resulting in insulin deficiency and hyperglycemia and current treatments for type I diabetes focus on controlling blood sugar with insulin therapy and must continue throughout a person's life.

Advertisement

In the new study, researchers at Saint Louis University focused on blocking the autoimmune process that destroys beta cells and leads to diabetes, with the aim of developing therapies that can prevent the illness from developing rather than treating its symptoms.

Researcher Thomas Burris said that none of the animals on the treatment developed diabetes even when they started treatment after significant beta cell damage had already occurred and they believe this type of treatment would slow the progression of type I diabetes in people or potentially even eliminate the need for insulin therapy.
Advertisement

Scientists already knew that at least two types of immune "T-cells" contribute to the development of type I diabetes, but the role of a third type, TH17, remained unclear.

In this study, researchers found that two nuclear receptors play critical roles in the development of TH17 cells and that by targeting these receptors, they were able to stop autoimmunity from developing in several mouse models, sparing beta cells.

The team blocked the receptors (ROR alpha and gamma t) with SR1001 (a selective ROR alpha and gamma t-inverse agonist developed by Burris), significantly reducing diabetes in mice that were treated with it.

These results confirm that TH17 cells likely play a key role in the development of type I diabetes and suggest that the use of drugs that target this cell type may offer a new treatment for the illness.

The study is published in Endocrinology.

Source: ANI
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Diabetes News

Why Is Losing a Pancreatic Cell Contributing to Diabetes?
Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.
New Artificial Pancreas can Help Your Child with Diabetes: Here's How
Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.
Bright Lights, Big Risk: Alarming Link Between Light Exposure and Gestational Diabetes!
New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.
 Ease Diabetic Neuropathy Pain With Spinal Cord Stimulation
Spinal cord stimulation delivers electrical stimulation to the spinal cord to cut off pain signals to the brain and may ease pain associated with diabetic neuropathy.
How Digital Therapeutics Improve Blood Sugar Levels?
Cognitive behavioral therapy delivered via smartphone app was found to lower blood sugar levels in type 2 diabetes people.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Type 1 Diabetes Development Halted in Lab Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests